TY - JOUR AU - Ririn Widyastuti PY - 2018/12/29 Y2 - 2024/03/29 TI - Iron Supplementation Tablet (Fe) on Pregnant Women in Bakunase Health Center in 2018 JF - Proceeding 1st. International Conference Health Polytechnic of Kupang JA - ichpk VL - 0 IS - 0 SE - Articles DO - UR - https://proceeding.poltekeskupang.ac.id/index.php/ichpk/article/view/28 AB - Background: Based on Data Riset Kesehatan Dasar (Riskesdas) in 2018 shows an increase in anemia cases. In 2013 anemia cases were recorded at 37.1% and there was an increase in 2018 to 48.9% (Kemenkes, 2018). The most common cause of anemia is iron deficiency caused by an imbalance of iron reserves, inadequate iron intake and absorption, increased iron requirements during pregnancy or growth processes and due to worm infections (WHO, 2014).  The aim of the study was to determine the administration of iron supplementation on pregnant women at Bakunase Health Center in 2018. Research Methods: The type of research used was descriptive quantitative with approach cross-sectional. The study was conducted in September - October 2018 at the Kupang Bakunase Health Center. The population in this study were all pregnant women in the working area of ​​the Bakunase Community Health Center in 2018 totaling 276 people. The sampling technique was accidental sampling which amounted to 74 people. Results: 74 respondents of 100 % of pregnant women received iron supplemented tablets (Fe). When giving Fe, there were 33 respondents (44.6%) who received Fe in the first trimester at <14 weeks of gestation. 26 respondents (35.1%) received Fe <90 tablets. This is because it is not yet time to get a TTD and 48 respondents (64.9%) have received a Fe of 90 tablets. 13 respondents (17.6%) who did not spend the Fe given for lazy reasons 3 respondents (23.1), Forgotten / irregular 2 respondents (15.4%) and could not stand the side effects 8 (10.8%). Information related to side effects from consumption of Fe was obtained from health workers, either doctors or midwives, amounting to 74 respondents (100%). Respondents received Fe from Health facilities in either the hospital or health center as many as 66 respondents (89.2%) and the rest received TTD from the Pharmacy 8 respondents (10.8%). 57 respondents (77%) said no one was watching in drinking Fe.  ER -